問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberDS7300-127
Active

2022-03-09 - 2026-12-15

Phase II

Recruiting6

ICD-10C34.90

Malignant neoplasm of unspecified part of unspecified bronchus or lung

ICD-10C34.91

Malignant neoplasm of unspecified part of right bronchus or lung

ICD-10C34.92

Malignant neoplasm of unspecified part of left bronchus or lung

ICD-10C7A.090

Malignant carcinoid tumor of the bronchus and lung

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9162.9

Malignant neoplasm of bronchus and lung, unspecified

xxxxxx

  • Trial Applicant

     Daiichi Sankyo Taiwan Ltd. 

  • Sponsor

    xxxxxx

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/02/01

Investigators and Locations

Principal Investigator Chun-Hui Lee Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator James Chih-Hsin Yang Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator CHIN-CHOU WANG Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chi-Lu Chiang Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 吳教恩 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator TSUNG -YING YANG

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

xxxxxx

Objectives

xxxxxx

Test Drug

xxxxxx

Active Ingredient

Ifinatamab Deruxtecan

Dosage Form

048

Dosage

100 mg

Endpoints

xxxxxx

Inclution Criteria

xxxxxx

Exclusion Criteria

xxxxxx

The Estimated Number of Participants

  • Taiwan

    15 participants

  • Global

    187 participants